Saku Koivu is one of the most beloved players to don the Montreal Canadiens sweater. He did not win Stanley Cups like Jean ...

Follicular lymphoma -- typically a slow-growing or indolent form of non-Hodgkin lymphoma that arises from B lymphocytes -- accounts for 20% to 30% of all non-Hodgkin lymphoma cases. The indolent ...

As Corunna High School’s Class of 2025 walked across the graduation stage in caps and gowns, 18-year-old Luke Dolehanty ...

Abby Lee Miller is spilling all to us about her lawsuit against Cedars-Sinai Marina del Rey Hospital -- recalling how after years of unbearable pain following her 2020 surgery, she ...

An agent that may fulfill these requirements is the glycan-binding protein Galectin-9 (Gal-9). Indeed, treatment with Gal-9 reduced total cell counts and cell viability of various B cell NHL cell ...

In the autumn of 2022, Freddie Cole was diagnosed with stage 4 Burkitts lymphoma, a rare cancer of both the bone marrow and the lymph system, which affects just 210 people in the UK each year. Freddie ...

Lymphoma treatment advances discussed at Roche forumRoche Pharmaceuticals, through its local representative Ebn Sina Medical, a fully owned subsidiary of Aamal Company, convened a workshop ...

Burkitt's lymphoma is the second commonest histological subtype of HIV-related lymphoma. The HIV-related BL resembles sporadic BL in that only 30% are EBV-positive and the characteristic c-myc ...

Roche's Genentech reports positive results from lymphoma trial Jun. 20, 2025 2:01 PM ET Roche Holding AG (RHHBY) Stock, RHHBF Stock, RHHVF Stock By: Nilanjana Basu, SA News Editor Play (1min) ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), presented today results from the Phase III SUNMO [ NCT05171647 ] study showing Lunsumio ® (mosunetuzumab-axgb) administered ...